Biotronik A.G. v. Conor Medsystems: Be Sure to Expressly Exclude Lost Profits in Drafting New York Law Contracts

by White & Case LLP
Contact

On March 27, 2014, the New York Court of Appeals held that a provision excluding both parties' liability for consequential damages would not preclude recovery of lost profits that the court found were the direct and probable result of a breach of the parties' exclusive distribution agreement.[1]

Biotronik A.G. ("Biotronik") and Conor Medsystems Ireland Ltd. ("Conor") entered into an exclusive distribution agreement in 2004, pursuant to which Biotronik agreed to be the exclusive distributor of CoStar, Conor's drug-eluting coronary stent, to end users and resellers in a specified territory.[2] The agreement required Biotronik to pay to Conor (for each calendar quarter during the term of the agreement) the higher of an agreed upon “minimum transfer price" per unit of CoStar shipped to Biotronik, or a fixed percentage of Biotronik's average net sales of CoStar.[3] Biotronik retained as profits from its CoStar sales any amounts earned above the agreed upon price, but if Biotronik sold zero CoStar units in a particular calendar quarter, Biotronik would still be required to pay the minimum transfer price to Conor. The agreement included a provision excluding both parties' liability for “any indirect, special, consequential, incidental or punitive damage with respect to any claim arising out of [the] agreement" for any reason, including a party's performance or breach of the agreement.[4]

In May 2007, Conor notified Biotronik that it was recalling CoStar and taking it off the market because FDA trials failed to establish that CoStar was equivalent to another widely-manufactured stent. Conor gave timely notice that it intended not to renew the contract beyond the initial term and reimbursed Biotronik for its costs and expenses associated with the CoStar recall in accordance with the contract's terms. Biotronik sued Conor for breach of contract and sought as general damages (not barred by the limitation of liability provision) the lost profits that Biotronik claimed it would have made reselling CoStar. The trial court held that the lost profits sought by Biotronik were unrecoverable consequential damages barred by the contract's limitation of liability provision, and the Appellate Division affirmed.[5]

The New York Court of Appeals, the highest court within the State of New York, reversed in a 4-3 decision, holding that the lost profits sought by Biotronik were the "direct and probable result of the breach of the parties' agreement and thus constitute general damages."[6] Because the contract did not specifically preclude recovery of lost profits or characterize lost profits as consequential damages, the court evaluated lost profits based on general contract principles.[7] The court noted that damages must be assessed in the context of the agreement because lost profits may be direct or consequential damages, "depending on whether the non-breaching party bargained for such profits and they are the 'direct and immediate fruits of the contract.'"[8] The court reviewed previous decisions and found that "[t]he distinction at the heart of these cases is whether the lost profits flowed directly from the contract itself" or would have been earned pursuant to a separate agreement with a third party.[9] The court found that, because the contract used Biotronik's resale price of the CoStar product as a benchmark for computing Biotronik's payments to Conor, the "very essence" of the agreement was that Biotronik would resell Conors stents, distinguishing this matter from a situation where the buyer's resale to third parties is independent of the contract.[10] The court found that both parties' profits flowed directly from the pricing formula and were dependent on the resale of CoStar, such that any lost profits resulting from a breach would be the natural and probable consequence of that breach.

The dissent noted that the agreement addressed complicated matters including discontinuance of manufacturing and product recalls, as well as limitations of liability, and criticized the majority for allowing Biotronik to circumvent the natural meaning of the agreed upon liability limitations.[11] The dissent disagreed that the contract dictated resale prices for CoStar or required Biotronik to resell CoStar units in order for Conor to be paid, noting that Biotronik was obligated to make minimum quarterly payments even if no units were sold during that quarter.[12] The dissent distinguished the pricing mechanisms in this matter from past cases where lost profits were held to be general damages based on contracts that specifically required the breaching party to pay the non-breaching party specified sums comprising the non-breaching party's future profits.[13] The dissent found, instead, that the damages in this case "flow from collateral transactions – Biotronik's contracts with its resale customers – rather than from any provision of the [a]greement requiring the breaching party to make a payment to the non-breaching party."[14] The dissent also found that past precedent dictated that "profits a non-breaching party loses on third-party transactions are consequential rather than general damages even though ‘the ability of the non-breaching party to . . . generate profits on [these] collateral transactions, is contingent on the performance of the primary contract.'"[15]

This case highlights the importance of specifically identifying lost profits in contractual limitation of liability provisions and not just relying on a general reference excluding consequential damages. The need to specifically exclude lost profits is further highlighted in supply and distribution arrangements, particularly where financial models and compensation provisions expressly reference downstream transactions. According to the majority in Biotronik, these types of provisions essentially bring third party transactions within the scope of an agreement and allow for an argument that lost profits were a foreseeable form of general damages. Companies with contracts governed by New York law should review their existing contracts and ensure that all future contracts specifically exclude lost profits in any clause purporting to limit a party's liability for lost profits type consequential damages. This is an easy drafting tip that could help avoid costly litigation in the future.


[1] - Biotronik A.G. v. Conor Medsystems Ireland Ltd., et al., 2014 WL 1237514 (N.Y. March 27, 2014).
[2] - The agreement was governed by New York law and the initial term ran through the end of 2007, with an automatic one year renewal unless either party provided timely notice of its election not to renew the agreement.
[3] - Specifically, the agreement required Biotronik to pay to Conor a "minimum transfer price" for each unit of stents purchased by Biotronik per quarter, and the minimum transfer price would be agreed upon by the parties quarterly for the following calendar quarter. If the "transfer price" (calculated following the close of each quarter as a fixed percentage of Biotronik’s average net sales per unit for the calendar quarter in which a stent was supplied to Biotronik) exceeded the minimum transfer price that Biotronik paid to Conor, Biotronik agreed to pay the difference between the two figures to Conor.
[4] - Id *3. The complete provision reads: "Neither Party Shall Be Liable To the Other for Any Indirect, Special, Consequential, Incidental or Punitive Damage With Respect to Any Claim Arising Out of this Agreement (Including Without Limitation Its Performance or Breach of this Agreement) for Any Reason."
[5] - Biotronik A.G. v. Conor Medsystems Ireland Ltd., et al., 2011 NY Slip Op 51980(U) (N.Y. Sup. Ct. 2011), aff’d, 945 N.Y.S.2d 258 (N.Y. App. Div. 2012).
[6] - Biotronik A.G. v. Conor Medsystems Ireland Ltd., et al., 2014 WL 1237514 at *1.
[7] - Id. at *4.
[8] - Id. at *5.
[9] - Id. at *6.
[10] - Id. at *7-8.
[11] - Id. at *18 (Read, J., dissenting).
[12] - Id. at *11-12 (Read, J., dissenting).
[13] - Id. at *12-13 (Read, J., dissenting).
[14] - Id. at *18 (Read, J., dissenting).
[15] - Id. at *11 (Read, J., dissenting).

Written by:

White & Case LLP
Contact
more
less

White & Case LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
Feedback? Tell us what you think of the new jdsupra.com!